Promotions & Moves
Related Searches:
Filter by:
May 25, 2007
Dr. Frank Deane has been promoted to president, manufacturing at Lilly from his current role of vice president, quality. He will succeed Scott Canute, who has led the manufacturing organization since 2001. Mr. Canute, after six years of leading a tra…
Read More »
May 21, 2007
Pfizer Global R&D president Dr. John LaMattina will retire from Pfizer by the end of this year, after 30 years with the company. Pfizer has begun a search both inside and outside the company for his successor, and Dr. LaMattina will remain during…
Read More »
May 18, 2007
William J. Sharbaugh has been named chief operating officer, PPD, effective May 31. Mr. Sharbaugh joins the company from Bristol-Myers Squibb, where he most recently served as vice president, global development operations, responsible for strategic d…
Read More »
May 18, 2007
Patricia A. Steigerwald, MS, RN has been promoted to vice president, Global Late Phase, Kendle. In this role she will provide executive leadership to drive continued growth of the company's Late Phase brand globally, with a focus on the design and co…
Read More »
May 17, 2007
Braham Shroot, Ph.D. has been appointed chief scientific officer of Barrier Therapeutics. In this role, he will manage the company's R&D activities, reporting to Geert Cauwenbergh, Ph.D., chief executive officer.
"Dr. Shroot's extensive…
Read More »
May 15, 2007
Dr. John Yates has been appointed to the newly created position of chief medical officer at Array BioPharma, Inc. Dr. Yates will oversee the medical strategy and clinical development of the company's cancer and inflammation pipeline.
"John…
Read More »
May 14, 2007
Lee Babiss, Ph.D. has been named head of global pharma research, Roche, effective July 1, 2007. In this new role, Dr. Babiss will be based in Basel, Switzerland, and focus on leading and managing research within the company's five disease biology are…
Read More »
May 14, 2007
Manni Kantipudi has been named president, GVK Biosciences and will be based out of the corporate office in India. Mr. Manni will be responsible for operations and helping the company grow as a service provider to global pharmaceutical and biotechnolo…
Read More »
May 11, 2007
Dr. James M. Pusey has been appointed vice president and general manager of MDS Pharma Services global clinical development business, which manages late-stage drug trials. Dr. Pusey has more than 25 years of experience in medicine, global clinical tr…
Read More »
May 10, 2007
Paul Carter has been named senior vice president, international commercial operations, Gilead Sciences, Inc. Mr. Carter is responsible for the company's commercial organization in all territories outside North America, reporting to Kevin Young, Gile…
Read More »
May 8, 2007
Parexel has appointed Joe Avellone, M.D. to the position of vice president of operations for Clinical Research Services, Americas. Dr. Avellone will lead operational aspects of the company's Phase II-IV clinical development programs for clients, incl…
Read More »
May 8, 2007
IPS has appointed Eugene K. Martini, P.E. to the role of senior director, Project Delivery Operations. In this role, Mr. Martini will oversee day-to-day operations of Project Delivery Operations at IPS. He brings 25 years of experience in the managem…
Read More »
May 7, 2007
Eli Lilly and Co. has announced changes in the company's senior leadership team. Alex M. Azar II will be joining the company as senior vice president of corporate affairs and communications, reporting directly to chairman and chief executive officer…
Read More »
May 4, 2007
Joseph Zakrzewski has been appointed chief executive officer of Xcellerex, Inc. and a member of the company's board of directors. Mr. Zakrzewski joins the company after a 20-year career at Eli Lilly and Co. and most recently as chief operating office…
Read More »
May 1, 2007
Linda Baddour, chief financial and accounting officer of PPD, Inc., is resigning from her position effective May 31, 2007. Ms. Baddour will provide consulting services to the company for the next six months to assist with the transition of her respon…
Read More »
